GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biostar Pharmaceuticals, Inc. (BSPM) [hlAlert]

Rating:
Mkt Outperform
BSPM
down 92.07 %

Biostar Pharmaceuticals, Inc.: OTC:BSPM quotes & news (BSPM) rated Mkt Outperform with price target $7 by Rodman & Renshaw

Posted on: Thursday,  Nov 18, 2010  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) on 11/18/2010, when the stock price was $8.58.
Since then, Biostar Pharmaceuticals, Inc. has lost 92.07% as of 08/27/2015's recent price of $0.68.
If you would have followed this Rodman & Renshaw's recommendation on BSPM, you would have lost 92.07% of your investment in 1743 days.

Biostar Pharmaceuticals, Inc. (Biostar), through its subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical), is engaged in the business of discovering, developing, manufacturing and marketing of over-the-counter (OTC) and prescription pharmaceutical products, as well as medical supplement products. The Company?s medical supplement products include capsules, granules and powder type medicines for a variety of diseases and conditions, such as hepatitis, gynecopathy and various male diseases. Shaanxi Biostar BioTech Ltd (Shaanxi Biostar) is the Company?s wholly owned subsidiary in the People?s Republic of China. Aoxing Pharmaceutical?s products are derived from medicinal herbs. Aoxing Pharmaceutical manufactures five drugs and ten nutrients, which are sold in over 30 provinces in the People?s Republic of China.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2010 8:25 AM Buy
None
8.58 21.00
as of 12/31/2010
1 Week down  -7.55 %
1 Month down  -8.86 %
3 Months down  -8.86 %
1 YTD down  -8.86 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy